Zoetis
Draxxin 25 mg/ml - cattle, pigs and sheeps - 250 ml

Treatment and metaphylaxis of respiratory diseases in cattle, pigs and sheeps

Prescription required* (Exceptions apply)

Draxxin is a colourless to slightly yellow solution for injection for cattles, pigs and sheeps

Each Draxxin ml contains:

  • Active substance:
Name Tulathromycin Monothioglycerol
Draxxin 25 mg/ml solution for injection for cattle, pigs and sheep 25.00 mg 5.00 mg
Draxxin 100 mg/ml solution for injection for cattle, pigs and sheep 100.00 mg 5.00 mg
  • List of excipients:
    • Monothioglycerol
    • Propylene glycol
    • Citric acid
    • Hydrochloric acid
    • Sodium hydroxide
    • Water for injections

Indications for use of Draxxin, specifying the target species:

  • Cattle:
    • Treatment and metaphylaxis of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis sensitive to tulathromycin. The presence of the disease in the herd should be established before metaphylactic treatment.
    • Treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis sensitive to tulathromycin.
  • Pigs:
    • Treatment and metaphylaxis of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Mycoplasma hyopneumoniae, Haemophilus parasuis and Bordetella bronchiseptica sensitive to tulathromycin. The presence of the disease in the herd should be established before metaphylactic treatment. Draxxin should only be used if pigs are expected to develop the disease within 2–3 days.
  • Sheep:
    • Treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent Dichelobacter nodosus requiring systemic treatment.
  • Do not use in case of hypersensitivity of the target animals to macrolide antibiotics.
  • Do not use simultaneously with other macrolides or lincosamides.
  • Do not use in lactating animals producing milk for human consumption.
  • Do not use in pregnant animals, which are intended to produce milk for human consumption, within 2 months of expected parturition.

    Draxxin Withdrawal periods:

  • Cattle (meat and offal): 22 days.
  • Pigs (meat and offal): 13 days.
  • Sheep (meat and offal): 16 days.
  • Not authorised for use in animals producing milk for human consumption.
  • Do not use in pregnant animals, which are intended to produce milk for human consumption, within 2 months of expected parturition.

Amounts of Draxxin to be administered and administration route:

  • To ensure correct dosage bodyweight should be determined as accurately as possible to avoid underdosing. For multiple vial entry, an aspirating needle or multi-dose syringe is recommended to avoid excessive broaching of the stopper.
  • Cattle:
    • Subcutaneous use.
    • A single subcutaneous injection of 2.5 mg tulathromycin/kg bodyweight (equivalent to 1 ml/40 kg bodyweight). For treatment of cattle over 300 kg bodyweight, divide the dose so that no more than 7.5 ml are injected at one site.
  • Pigs:
    • Intramuscular use.
    • A single intramuscular injection of 2.5 mg tulathromycin/kg bodyweight (equivalent to 1 ml/40 kg bodyweight) in the neck.
    • For treatment of pigs over 80 kg bodyweight, divide the dose so that no more than 2 ml are injected at one site.
    • For any respiratory disease, it is recommended to treat animals in the early stages of the disease and to evaluate the response to treatment within 48 hours after injection.
    • If clinical signs of respiratory disease persist or increase, or if relapse occurs, treatment should be changed, using another antibiotic, and continued until clinical signs have resolved.
  • Sheep:
    • Intramuscular use.
    • A single intramuscular injection of 2.5 mg tulathromycin/kg body weight (equivalent to 1 ml/40 kg body weight) in the neck.

Draxxin is a colourless to slightly yellow solution for injection for cattles, pigs and sheeps

Each Draxxin ml contains:

  • Active substance:
Name Tulathromycin Monothioglycerol
Draxxin 25 mg/ml solution for injection for cattle, pigs and sheep 25.00 mg 5.00 mg
Draxxin 100 mg/ml solution for injection for cattle, pigs and sheep 100.00 mg 5.00 mg
  • List of excipients:
    • Monothioglycerol
    • Propylene glycol
    • Citric acid
    • Hydrochloric acid
    • Sodium hydroxide
    • Water for injections

Indications for use of Draxxin, specifying the target species:

  • Cattle:
    • Treatment and metaphylaxis of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis sensitive to tulathromycin. The presence of the disease in the herd should be established before metaphylactic treatment.
    • Treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis sensitive to tulathromycin.
  • Pigs:
    • Treatment and metaphylaxis of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Mycoplasma hyopneumoniae, Haemophilus parasuis and Bordetella bronchiseptica sensitive to tulathromycin. The presence of the disease in the herd should be established before metaphylactic treatment. Draxxin should only be used if pigs are expected to develop the disease within 2–3 days.
  • Sheep:
    • Treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent Dichelobacter nodosus requiring systemic treatment.
  • Do not use in case of hypersensitivity of the target animals to macrolide antibiotics.
  • Do not use simultaneously with other macrolides or lincosamides.
  • Do not use in lactating animals producing milk for human consumption.
  • Do not use in pregnant animals, which are intended to produce milk for human consumption, within 2 months of expected parturition.

    Draxxin Withdrawal periods:

  • Cattle (meat and offal): 22 days.
  • Pigs (meat and offal): 13 days.
  • Sheep (meat and offal): 16 days.
  • Not authorised for use in animals producing milk for human consumption.
  • Do not use in pregnant animals, which are intended to produce milk for human consumption, within 2 months of expected parturition.

Amounts of Draxxin to be administered and administration route:

  • To ensure correct dosage bodyweight should be determined as accurately as possible to avoid underdosing. For multiple vial entry, an aspirating needle or multi-dose syringe is recommended to avoid excessive broaching of the stopper.
  • Cattle:
    • Subcutaneous use.
    • A single subcutaneous injection of 2.5 mg tulathromycin/kg bodyweight (equivalent to 1 ml/40 kg bodyweight). For treatment of cattle over 300 kg bodyweight, divide the dose so that no more than 7.5 ml are injected at one site.
  • Pigs:
    • Intramuscular use.
    • A single intramuscular injection of 2.5 mg tulathromycin/kg bodyweight (equivalent to 1 ml/40 kg bodyweight) in the neck.
    • For treatment of pigs over 80 kg bodyweight, divide the dose so that no more than 2 ml are injected at one site.
    • For any respiratory disease, it is recommended to treat animals in the early stages of the disease and to evaluate the response to treatment within 48 hours after injection.
    • If clinical signs of respiratory disease persist or increase, or if relapse occurs, treatment should be changed, using another antibiotic, and continued until clinical signs have resolved.
  • Sheep:
    • Intramuscular use.
    • A single intramuscular injection of 2.5 mg tulathromycin/kg body weight (equivalent to 1 ml/40 kg body weight) in the neck.
269.10
Order within 22h 11m 43s (before 12AM)
And receive your order
on Monday 23 September
AIR FREIGHT

Customers who buy this product, usually buy: